These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35459867)

  • 1. Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson's disease.
    Chalazonitis A; Rao M; Sulzer D
    NPJ Parkinsons Dis; 2022 Apr; 8(1):50. PubMed ID: 35459867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral dopamine neurotrophic factor is essential for enteric neuronal development, maintenance, and regulation of gastrointestinal transit.
    Chalazonitis A; Li Z; Pham TD; Chen J; Rao M; Lindholm P; Saarma M; Lindahl M; Gershon MD
    J Comp Neurol; 2020 Oct; 528(14):2420-2444. PubMed ID: 32154930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral dopamine neurotrophic factor-deficiency leads to degeneration of enteric neurons and altered brain dopamine neuronal function in mice.
    Lindahl M; Chalazonitis A; Palm E; Pakarinen E; Danilova T; Pham TD; Setlik W; Rao M; Võikar V; Huotari J; Kopra J; Andressoo JO; Piepponen PT; Airavaara M; Panhelainen A; Gershon MD; Saarma M
    Neurobiol Dis; 2020 Feb; 134():104696. PubMed ID: 31783118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
    O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD.
    Corbillé AG; Coron E; Neunlist M; Derkinderen P; Lebouvier T
    J Parkinsons Dis; 2014; 4(4):571-6. PubMed ID: 25055959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature of catecholamine-containing neurons in the enteric nervous system in relationship with organogenesis, normal human anatomy and neurodegeneration.
    Natale G; Ryskalin L; Busceti CL; Biagioni F; Fornai F
    Arch Ital Biol; 2017 Sep; 155(3):118-130. PubMed ID: 29220864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteric nervous system manifestations of neurodegenerative disease.
    Chalazonitis A; Rao M
    Brain Res; 2018 Aug; 1693(Pt B):207-213. PubMed ID: 29360466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System.
    Memic F; Knoflach V; Morarach K; Sadler R; Laranjeira C; Hjerling-Leffler J; Sundström E; Pachnis V; Marklund U
    Gastroenterology; 2018 Feb; 154(3):624-636. PubMed ID: 29031500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Golgi complex of dopaminergic enteric neurons is fragmented in a hemiparkinsonian rat model.
    Cara-Esteban M; Marín MP; Martínez-Alonso E; Martínez-Bellver S; Teruel-Martí V; Martínez-Menárguez JA; Tomás M
    Microsc Res Tech; 2024 Feb; 87(2):373-386. PubMed ID: 37855309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism.
    Lindholm P; Saarma M
    Mol Psychiatry; 2022 Mar; 27(3):1310-1321. PubMed ID: 34907395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial Cells as Possible Targets of Neuroprotection through Neurotrophic and Antioxidative Molecules in the Central and Enteric Nervous Systems in Parkinson's Disease.
    Isooka N; Miyazaki I; Asanuma M
    Acta Med Okayama; 2021; 75(5):549-556. PubMed ID: 34703037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squalamine Restores the Function of the Enteric Nervous System in Mouse Models of Parkinson's Disease.
    West CL; Mao YK; Delungahawatta T; Amin JY; Farhin S; McQuade RM; Diwakarla S; Pustovit R; Stanisz AM; Bienenstock J; Barbut D; Zasloff M; Furness JB; Kunze WA
    J Parkinsons Dis; 2020; 10(4):1477-1491. PubMed ID: 32925094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinacrine and Niclosamide Promote Neurite Growth in Midbrain Dopaminergic Neurons Through the Canonical BMP-Smad Pathway and Protect Against Neurotoxin and α-Synuclein-Induced Neurodegeneration.
    Goulding SR; Lévesque M; Sullivan AM; Collins LM; O'Keeffe GW
    Mol Neurobiol; 2021 Jul; 58(7):3405-3416. PubMed ID: 33713017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys.
    Li X; Yang W; Li X; Chen M; Liu C; Li J; Yu S
    Neurosci Lett; 2020 Jan; 716():134640. PubMed ID: 31759083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson's Disease.
    Anantha J; Goulding SR; Tuboly E; O'Mahony AG; Moloney GM; Lomansey G; McCarthy CM; Collins LM; Sullivan AM; O'Keeffe GW
    Mol Neurobiol; 2022 Jan; 59(1):61-76. PubMed ID: 34623600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid accumulation drives cellular senescence in dopaminergic neurons.
    Russo T; Riessland M
    Aging (Albany NY); 2024 Jul; 16(14):11128-11133. PubMed ID: 39033779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.
    Manfredsson FP; Luk KC; Benskey MJ; Gezer A; Garcia J; Kuhn NC; Sandoval IM; Patterson JR; O'Mara A; Yonkers R; Kordower JH
    Neurobiol Dis; 2018 Apr; 112():106-118. PubMed ID: 29341898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy.
    Lionnet A; Wade MA; Corbillé AG; Prigent A; Paillusson S; Tasselli M; Gonzales J; Durieu E; Rolli-Derkinderen M; Coron E; Duchalais E; Neunlist M; Perkinton MS; Hanger DP; Noble W; Derkinderen P
    Acta Neuropathol Commun; 2018 Jul; 6(1):65. PubMed ID: 30037345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
    Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
    Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current disease modifying approaches to treat Parkinson's disease.
    Lindholm D; Mäkelä J; Di Liberto V; Mudò G; Belluardo N; Eriksson O; Saarma M
    Cell Mol Life Sci; 2016 Apr; 73(7):1365-79. PubMed ID: 26616211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.